ＪＣＲファーマ：JR-141 (Pabinafusp Alfa) for Hunter Syndrome Notice on the Publication of the Results of the Phase 2・3 Clinical Trials in Molecular Therapy - 有報キャッチャー

ＪＣＲファーマ（4552）　JR-141 (Pabinafusp Alfa) for Hunter Syndrome Notice on the Publication of the Results of the Phase 2・3 Clinical Trials in Molecular Therapy 2020/10/15

/-

読み込み中…